Target Name: RNF150
NCBI ID: G57484
Review Report on RNF150 Target / Biomarker Content of Review Report on RNF150 Target / Biomarker
RNF150
Other Name(s): KIAA1214 | Ring finger protein 150 | ring finger protein 150 | RN150_HUMAN | RING finger protein 150

KIAA1214: A Potential Drug Target for RNA-Folding Disorders

RNA-Nucleic Acid (RNA) folding is a fundamental process that occurs in all living organisms, and it plays a crucial role in the regulation of gene expression. RNA-folding disorders, such as RNA-Nucleic Acid (RNANA) diseases, are a group of genetic disorders caused by defects in RNA-folding machinery, leading to the misfolding and misregulation of RNA molecules.

One of the key proteins involved in RNA-folding is KIAA1214, also known as RNF150. It is a non-coding RNA molecule that plays a critical role in the regulation of RNA-folding by the poly(A)1+-rich transformation RNA (PAI) machinery.

KIAA1214 is a 14-kDa protein that contains 115 amino acid residues. It is expressed in most tissues and cells and is involved in the regulation of various cellular processes, including cell growth, differentiation, and RNA-folding.

One of the key functions of KIAA1214 is its ability to interact with PAI, which is a protein that plays a central role in the regulation of RNA-folding by the poly(A)1+-rich transforming RNA (PAI) machinery. PAI is a highly conserved protein that contains a N-terminal transmembrane domain, a core domain, and a C-terminal T-loop region. It functions as a scaffold to recruit other proteins to the RNA-folding machinery, including KIAA1214.

In recent years, researchers have become increasingly interested in KIAA1214 as a potential drug target or biomarker for RNA-folding disorders. One of the reasons for this interest is the potential therapeutic benefits of targeting KIAA1214. KIAA1214 has been shown to play a critical role in the regulation of RNA-folding by the PAI machinery, which could make it an attractive target for small molecules that can modulate the activity of PAI. Additionally, KIAA1214 is overexpressed in many diseases, including cancer, which could make it an attractive biomarker for these diseases.

Another promising aspect of KIAA1214 is its role in the regulation of cellular processes that are relevant to many diseases, including cancer. KIAA1214 has been shown to play a role in the regulation of cell growth, apoptosis, and angiogenesis, which are all processes that are disrupted in many diseases, including cancer. Additionally, KIAA1214 has been shown to be involved in the regulation of theNotch signaling pathway, which is a highly conserved signaling pathway that is involved in many cellular processes, including cancer.

In conclusion, KIAA1214 is a non-coding RNA molecule that plays a critical role in the regulation of RNA-folding by the poly(A)1+-rich transforming RNA (PAI) machinery. Its functions as a potential drug target or biomarker for RNA-folding disorders and its role in the regulation of cellular processes that are relevant to many diseases make it an attractive target for small molecules that can modulate its activity. Further research is needed to fully understand the role of KIAA1214 in the regulation of RNA- folding and its potential as a drug target or biomarker.

Protein Name: Ring Finger Protein 150

The "RNF150 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNF150 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

RNF151 | RNF152 | RNF157 | RNF157-AS1 | RNF165 | RNF166 | RNF167 | RNF168 | RNF169 | RNF17 | RNF170 | RNF175 | RNF180 | RNF181 | RNF182 | RNF183 | RNF185 | RNF186 | RNF187 | RNF19A | RNF19B | RNF2 | RNF20 | RNF207 | RNF208 | RNF212 | RNF212B | RNF213 | RNF213-AS1 | RNF214 | RNF215 | RNF216 | RNF216-IT1 | RNF216P1 | RNF217 | RNF217-AS1 | RNF220 | RNF222 | RNF224 | RNF225 | RNF227 | RNF24 | RNF25 | RNF26 | RNF31 | RNF32 | RNF32-DT | RNF34 | RNF38 | RNF39 | RNF4 | RNF40 | RNF41 | RNF43 | RNF44 | RNF5 | RNF5P1 | RNF6 | RNF7 | RNF7P1 | RNF8 | RNFT1 | RNFT2 | RNGTT | RNH1 | RNLS | RNMT | RNPC3 | RNPC3-DT | RNPEP | RNPEPL1 | RNPS1 | RNPS1P1 | RNR1 | RNR2 | RNU1-1 | RNU1-100P | RNU1-108P | RNU1-11P | RNU1-134P | RNU1-18P | RNU1-3 | RNU1-31P | RNU1-32P | RNU1-36P | RNU1-38P | RNU1-4 | RNU1-42P | RNU1-55P | RNU1-61P | RNU1-63P | RNU1-72P | RNU1-73P | RNU1-78P | RNU1-7P | RNU1-82P | RNU1-88P | RNU105B | RNU11 | RNU12